Cargando…
Axillary surgery in node-positive breast cancer()
Long-term follow-up data from multicenter phase III non-inferiority trials confirmed the safety of omission of axillary dissection in selected patients with clinically node-negative, sentinel node-positive breast cancer. Several ongoing trials investigate extended eligibility of the Z0011 protocol i...
Autores principales: | Maggi, Nadia, Nussbaumer, Rahel, Holzer, Liezl, Weber, Walter P. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9097794/ https://www.ncbi.nlm.nih.gov/pubmed/34511332 http://dx.doi.org/10.1016/j.breast.2021.08.018 |
Ejemplares similares
-
Tailored axillary surgery – A novel concept for clinically node positive breast cancer
por: Heidinger, Martin, et al.
Publicado: (2023) -
Association of Axillary Dissection With Systemic Therapy in Patients With Clinically Node-Positive Breast Cancer
por: Weber, Walter P., et al.
Publicado: (2023) -
Predictors of axillary node response in node-positive patients undergoing neoadjuvant chemotherapy for breast cancer
por: Ladak, Farah, et al.
Publicado: (2022) -
Tailored axillary surgery with or without axillary lymph node dissection followed by radiotherapy in patients with clinically node-positive breast cancer (TAXIS): study protocol for a multicenter, randomized phase-III trial
por: Henke, Guido, et al.
Publicado: (2018) -
The Prognostic Significance of the Lymph Node Ratio in Axillary Lymph Node Positive Breast Cancer
por: Kim, Ji-Yoon, et al.
Publicado: (2011)